Replenix Gly-Sal 2-2

Description

Gly/Sal 2-2 is a pore refining cleanser formulated with 2% glycolic acid and 2% salicylic acid USP. This product is designed to effectively cleanse the skin while promoting exfoliation and refining the appearance of pores. It is presented in a net volume of 6.7 fluid ounces (200 ml).

Uses and Indications

This drug is indicated as a skin cleanser for the treatment of acne. It is designed to help reduce the severity and frequency of acne lesions in affected individuals.

Dosage and Administration

The affected area should be wetted prior to application. The product is to be applied directly to the area and rinsed thoroughly afterward.

Initial treatment should begin with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. In cases where bothersome dryness occurs, it is recommended to reduce the application frequency to once daily or every other day.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth to prevent irritation or adverse reactions.

Caution is advised when using this product in conjunction with other topical medications, as this may exacerbate dryness or irritation. Should such symptoms occur, it is recommended to discontinue use and consult a healthcare professional for further evaluation.

This product should be kept out of the reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

The use of sunscreen is strongly recommended when utilizing any glycolic acid product, as well as for an additional week following its use. This precaution is particularly important as some individuals may exhibit increased sensitivity to sunlight.

Side Effects

Patients using this product should be aware that it is for external use only and must be kept away from the eyes, lips, and mouth. The use of other topical medications concurrently or immediately after applying this product may lead to increased dryness or irritation. In such cases, patients are advised to discontinue use and consult their healthcare provider.

It is crucial to keep this product out of the reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center for guidance.

Additionally, the use of sunscreen is recommended when using this product, particularly for individuals utilizing glycolic acid products, as they may experience heightened sensitivity to sunlight. This precaution should be maintained for at least one week following the cessation of use.

Drug Interactions

The concurrent use of other topical medications with this product may lead to increased dryness or irritation of the skin. In such cases, it is advised to discontinue the use of this product and consult a healthcare professional for further evaluation and guidance. Monitoring for signs of skin irritation is recommended when using this product alongside other topical agents.

Packaging & NDC

Below are the non-prescription pack sizes of Replenix Gly-Sal 2-2 (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the product out of reach of children. In the event of accidental ingestion, medical assistance should be sought or a Poison Control Center contacted.

For topical application, it is recommended to initiate treatment with one application daily. The frequency may be gradually increased to two or three times daily based on clinical need or physician direction. Care should be taken to monitor for excessive drying of the skin; if this occurs, the application frequency should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of Replenix Gly-Sal 2-2 in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as the absence of data necessitates careful consideration of individual patient factors and potential risks. Monitoring for any adverse effects is advisable, given the lack of established guidelines for this population.

Pregnancy

The safety of this product during pregnancy has not been established. Use of this product is contraindicated in pregnancy due to potential risks to the fetus. There may be risks associated with the use of salicylic acid during pregnancy; therefore, it is essential for pregnant patients to consult a healthcare provider for advice.

Dosage adjustments may be necessary for pregnant individuals, and medical guidance should be sought before use. Pregnant women should avoid using this product unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific contraindications. However, as with any medication, the benefits and risks should be assessed on a case-by-case basis, taking into account the health of the mother and the breastfed infant.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the event of an overdosage, immediate medical assistance is essential. Healthcare professionals are advised to seek medical help or contact a Poison Control Center if the substance is ingested.

Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is crucial. Prompt recognition of symptoms can facilitate timely intervention and management.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise during the course of treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of the reach of children to prevent accidental ingestion. In the event that the product is swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Additionally, it is important to inform patients about the use of sunscreen. They should be advised to apply sunscreen when using any glycolic acid product and to continue its use for an additional week after discontinuation, as some individuals may experience increased sensitivity to sunlight during this period.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the product is topical. Clinicians should advise patients to use sunscreen when using any glycolic acid product and to continue its use for an additional week afterward, as some individuals may exhibit increased sensitivity to sunlight.

Drug Information (PDF)

This file contains official product information for Replenix Gly-Sal 2-2, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)